secwatch.observer — SEC 8-K summary
======================================

Issuer:     LivaNova PLC (LIVN)
CIK:        0001639691
Form:       8-K
Filed at:   2023-03-24T23:59:59+00:00
Accession:  0001639691-23-000025
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LivaNova completes enrollment of 500th unipolar patient in RECOVER depression trial
--------------------------------------------------------------------------------

- Independent committee advised enrollment to continue from 475 to 500 unipolar patients per protocol.
- 500th unipolar patient randomized on March 23, 2023; final analysis after 12-month follow-up data.
- Trial evaluates Vagus Nerve Stimulation for difficult-to-treat depression; results to be published.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1639691/000163969123000025/0001639691-23-000025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1639691/000163969123000025/livn-20230322.htm
  HTML page:      https://secwatch.observer/filing/0001639691-23-000025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer